Galapagos N.V. (GLPG) Financials
Stock symbol GLPG is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker GLPG was renamed to
LKFT
effective 2026-05-08.
GLPG Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 4.0 billion | 200.3 million |
| Sept. 30, 2025 | 4.8 billion | 1.5 billion |
| June 30, 2025 | 4.5 billion | 1.4 billion |
| March 31, 2025 | 4.4 billion | 1.4 billion |
GLPG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -50.8 million | ? |
| Sept. 30, 2025 | -76.8 million | -14.9 million |
| June 30, 2025 | -133.1 million | ? |
| March 31, 2025 | -47.4 million | ? |
GLPG Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 918.2 million |
| Sept. 30, 2025 | -237.2 million |
| June 30, 2025 | -124.6 million |
| March 31, 2025 | -166.0 million |
GLPG Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 3.5 billion | 12.2 million | 6.1 million |
| Sept. 30, 2025 | 4.2 billion | 7.9 million | 7.9 million |
| June 30, 2025 | 3.6 billion | 7.1 million | 10.0 million |
| March 31, 2025 | 3.6 billion | 8.4 million | 11.7 million |
GLPG Shares Outstanding
GLPG Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 1.9 million | 126.2 million | 66.0 million | 5.2 million |
| Sept. 30, 2025 | 3.3 million | 86.7 million | 40.5 million | 3.3 million |
| June 30, 2025 | 4.9 million | 112.3 million | 22.2 million | -4.3 million |
| March 31, 2025 | 5.7 million | 197.7 million | 47.4 million | 4.5 million |
GLPG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 1.1 billion | 539.8 million |
| Sept. 30, 2025 | 83.5 million | 12.7 million |
| June 30, 2025 | 77.0 million | 5.5 million |
| March 31, 2025 | 81.1 million | 14.9 million |
GLPG
Price: $28.62
52 week price:
Earnings Per Share: -7.96 USD
P/E Ratio: -4.28
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Belgium
Volume: 69406
Ebitda: -23.5 millionMarket Capitalization: 1.9 billion